Literature DB >> 20718634

G protein-coupled receptor oligomerization for what?

Francisco Ciruela1, Antoni Vallano, Josep M Arnau, Silvia Sánchez, Dasiel O Borroto-Escuela, Luigi F Agnati, Kjell Fuxe, Víctor Fernández-Dueñas.   

Abstract

Although the G protein-coupled receptor (GPCR) oligomerization has been questioned during the last decade, under some premises the existence of a supramolecular organization of these receptors begins now to be widely accepted by the scientific community. Indeed, GPCR oligomers may enhance the diversity and performance by which extracellular signals are transferred to the G proteins in the process of receptor transduction, although the mechanism that underlie this phenomenon remains still unexplained. Recently, a trans-conformational switching model has been proposed as a mechanism allowing direct inhibition of receptor activation. Thus, heterotropic receptor-receptor allosteric regulations are behind the GPCR oligomeric function. Accordingly, we revise here how GPCR oligomerization impinge in several important receptor functions like biosynthesis, plasma membrane diffusion or velocity, pharmacology and signaling. Overall, the rationale of receptor oligomerization might lie in the cellular need of sensing complex extracellular signals and to translate into a simple computational mode.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20718634     DOI: 10.3109/10799893.2010.508166

Source DB:  PubMed          Journal:  J Recept Signal Transduct Res        ISSN: 1079-9893            Impact factor:   2.092


  7 in total

1.  Transmembrane domains of attraction on the TSH receptor.

Authors:  Rauf Latif; M Rejwan Ali; Mihaly Mezei; Terry F Davies
Journal:  Endocrinology       Date:  2014-11-19       Impact factor: 4.736

2.  Two amino acids in each of D1 and D2 dopamine receptor cytoplasmic regions are involved in D1-D2 heteromer formation.

Authors:  Brian F O'Dowd; Xiaodong Ji; Tuan Nguyen; Susan R George
Journal:  Biochem Biophys Res Commun       Date:  2011-11-12       Impact factor: 3.575

3.  Heteromerization Between the Bradykinin B2 Receptor and the Angiotensin-(1-7) Mas Receptor: Functional Consequences.

Authors:  Bruno D Cerrato; Oscar A Carretero; Brana Janic; Hernán E Grecco; Mariela M Gironacci
Journal:  Hypertension       Date:  2016-08-22       Impact factor: 10.190

4.  D5 dopamine receptor carboxyl tail involved in D5-D2 heteromer formation.

Authors:  Brian F O'Dowd; Tuan Nguyen; Xiaodong Ji; Susan R George
Journal:  Biochem Biophys Res Commun       Date:  2013-01-11       Impact factor: 3.575

5.  The Parkinson's disease-associated GPR37 receptor interacts with striatal adenosine A2A receptor controlling its cell surface expression and function in vivo.

Authors:  Xavier Morató; Rafael Luján; Marc López-Cano; Jorge Gandía; Igor Stagljar; Masahiko Watanabe; Rodrigo A Cunha; Víctor Fernández-Dueñas; Francisco Ciruela
Journal:  Sci Rep       Date:  2017-08-25       Impact factor: 4.379

6.  Angiotensin II type 1/adenosine A 2A receptor oligomers: a novel target for tardive dyskinesia.

Authors:  Paulo A de Oliveira; James A R Dalton; Marc López-Cano; Adrià Ricarte; Xavier Morató; Filipe C Matheus; Andréia S Cunha; Christa E Müller; Reinaldo N Takahashi; Víctor Fernández-Dueñas; Jesús Giraldo; Rui D Prediger; Francisco Ciruela
Journal:  Sci Rep       Date:  2017-05-12       Impact factor: 4.379

Review 7.  Contributions of fluorescence techniques to understanding G protein-coupled receptor dimerisation.

Authors:  Alan D Goddard; Anthony Watts
Journal:  Biophys Rev       Date:  2012-04-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.